Concurrent rearrangements of BCL2, BCL3, and BCL11A genes in atypical chronic lymphocytic leukemia

被引:13
|
作者
Podgornik, Helena [1 ]
Pretnar, Jozef [1 ]
Skopec, Barbara [1 ]
Andoljsek, Dusan [1 ]
Cernelc, Peter [1 ]
机构
[1] Univ Med Ctr Ljubljana, Dept Haematol, Ljubljana 1000, Slovenia
关键词
Atypical CLL; IGH translocation; t(2; 14); t(14; 19); t(18; 22); CHROMOSOMAL TRANSLOCATIONS; T(14/19)(Q32; Q13); PROGNOSIS; SURVIVAL; FEATURES; T(14/18);
D O I
10.1179/1607845413Y.0000000078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The most frequent chromosomal aberrations with the well established prognostic meaning in chronic lymphocytic leukemia (CLL) are + 12, del(11q), del(13q), and del(17p). Less common translocations lead to deregulation of genes primarily due to juxtaposition with IGH gene. We present a case of CLL patient with atypical morphology and an aggressive course of disease. In spite of aggressive treatment including allogeneic hematopoietic stem cell transplantation disease progressed into a rare cutaneous Richter's syndrome. Trisomy 12 was found as a sole chromosomal change at initial cytogenetic analysis of lymphoma cells. At progression, besides trisomy 12 three concomitant balanced translocations t(2; 14)(p13; q32), t(14; 19)(q32; q13), and t(18; 22)(q21; q11) were found. The same karyotype was confirmed in cells aspirated from skin infiltrates at Richter transformation. Atypical cytological features, trisomy 12, and a progressive course of disease observed in our case are typical for CLL with each of particular Ig translocations that were concomitantly found in CLL for the first time. Similar to "double hit" lymphoma concurrent rearrangements may be relevant also in CLL.
引用
收藏
页码:45 / 48
页数:4
相关论文
共 50 条
  • [21] Bcl-2 and apoptosis in chronic lymphocytic leukemia
    Aaron D. Schimmer
    Irene Munk-Pedersen
    Mark D. Minden
    John C. Reed
    Current Treatment Options in Oncology, 2003, 4 (3) : 211 - 218
  • [22] BCL3 TRANSLOCATION IS A FREQENT AND SELECTIVE EVENT IN CHRONIC LYMPHOCYTIC LEUKEMIA CARRYING+12
    Deambrogi, C.
    Cresta, S.
    Cerri, M.
    De Paoli, L.
    Capello, D.
    Gaidano, G.
    Rossi, D.
    HAEMATOLOGICA, 2008, 93 : S92 - S92
  • [23] Expert Variant Curation Combined with in-Silico analysis for Clinical Interpretation of BCL2 variants in Resistance to BCL2 Inhibitors in Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
    Mccoy, Matthew
    Rao, Shruti
    Cosgrove, Shannon
    Madhavan, Subha
    Kulkarni, Shashikant
    Xu, Xinjie
    Kanagal-Shamanna, Rashmi
    BLOOD, 2020, 136
  • [24] LACK OF 5' BCL2 REARRANGEMENTS IN B-CELL LEUKEMIA
    CROSSEN, PE
    MORRISON, MJ
    CANCER GENETICS AND CYTOGENETICS, 1993, 69 (01) : 72 - 73
  • [25] Detection of BCL2 rearrangements in follicular lymphoma
    Aster, JC
    Longtine, JA
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (03): : 759 - 763
  • [26] The BCL-1, BCL-2, and BCL-3 oncogenes are involved in chronic lymphocytic leukemia - Detection by fluorescence in situ hybridization
    Lishner, M
    Lalkin, A
    Klein, A
    Yarkoni, S
    Manor, Y
    Fejgin, M
    Leytin, V
    Ravid, M
    Amiel, A
    CANCER GENETICS AND CYTOGENETICS, 1995, 85 (02) : 118 - 123
  • [27] BCL2 expression in chronic lymphocytic leukemia:: lack of association with the BCL2-938A>C promoter single nucleotide polymorphism
    Majid, Aneela
    Tsoulakis, Olga
    Walewska, Renata
    Gesk, Stefan
    Siebert, Reiner
    Kennedy, D. Ben J.
    Dyer, Martin J. S.
    BLOOD, 2008, 111 (02) : 874 - 877
  • [28] Chronic Lymphocytic Leukemia With t(2;14)(p16;q32) Involves the BCL11A and IgH Genes and Is Associated With Atypical Morphologic Features and Unmutated IgVH Genes
    Yin, C. Cameron
    Lin, Katherine I-Chun
    Ketterling, Rhett P.
    Knudson, Ryan A.
    Medeiros, L. Jeffrey
    Barron, Lynn L.
    Huh, Yang O.
    Luthra, Rajyalakshmi
    Keating, Michael J.
    Abtuzzo, Lynne V.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (05) : 663 - 670
  • [29] High-Level ROR1 and BCL2, Cancer-Stemness, and BCL2 Mutations Associate with Venetoclax Resistance in Chronic Lymphocytic Leukemia
    Ghia, Emanuela M.
    Rassenti, Laura Z.
    Choi, Michael Y.
    Chu, Elvin
    Widhopf, George F., II
    Kipps, Thomas J.
    BLOOD, 2019, 134
  • [30] Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Lue, Jennifer K.
    Luttwak, Efrat
    Rivas-Delgado, Alfredo
    Irawan, Helen
    Boardman, Alexander
    Caron, Philip C.
    David, Kevin
    Epstein-Peterson, Zachary
    Falchi, Lorenzo
    Ghione, Paola
    Hamlin, Paul
    Horwitz, Steven M.
    Intlekofer, Andrew M.
    Johnson, William
    Kumar, Anita
    Moskowitz, Alison
    Noy, Ariela
    Palomba, M. Lia
    Steiner, Ralphael
    Stuver, Robert
    Torka, Pallawi
    Vardhana, Santosha
    Zelenetz, Andrew D.
    Schoder, Heiko
    Imber, Brandon
    Yahalom, Joachim
    Zhang, Yanming
    Galera, Pallavi
    Dogan, Ahmet
    Aypar, Umut
    Salles, Gilles
    BLOOD CANCER JOURNAL, 2024, 14 (01):